Railtown AI Technologies Inc. développe une solution d'intelligence artificielle de type logiciel en tant que service qui aide les équipes de développement de logiciels à détecter, analyser et corriger rapidement les erreurs dans leurs projets de développement (la « Plateforme »).
Railtown AI Technologies Inc. is in the business of developing a software-as-a-service artificial intelligence solution that helps software development teams detect, analyze and fix errors quickly in their development projects (the "Platform"). The Platform allows for real-time exception monitoring and alerting which permits developers, team managers and executives to quickly locate, understand and correct errors in their software development projects and their root causes, thereby preventing system and application downtimes.
Treatment.com est une start-up de technologie de santé perturbatrice qui exploite la puissance de l'IA pour aider les Canadiens à améliorer leur santé grâce à des recommandations et des informations personnalisées.
Treatment.com is a disruptive healthcare technology startup that is harnessing the power of AI to help Canadians improve their health through personalized recommendations and insights. Based in Vancouver, the Company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara.
L'Émetteur est une société d'investissement axée sur les industries des sports électroniques et des jeux mobiles, ainsi que sur tous les secteurs d'activité qui y sont liés.
Chaque bon de souscription donnera à son porteur le droit d'acquérir une (1) action ordinaire après la date d'émission et avant l'heure d'expiration, sur paiement du prix d'exercice de 0,70 $.
Voir l'acte de mandat pour plus de détails.
| File | Type | Date |
|---|---|---|
| FORM 7 MONTHLY PROGRESS REPORT | Monthly Progress Report | 04/03/2021 |
| Material Change Report | Material Change Report | 25/02/2021 |
| Form 6 - Certificate of Compliance | Certificate of compliance | 25/02/2021 |
| Form 9 - Notice of Issuance of Securities | Proposed Issuance of Listed Securities | 25/02/2021 |
| CDS Summary Report | Confirmation from CDS | 16/02/2021 |
| Indenture | Indenture | 16/02/2021 |
| Form 6 - Certificate of Compliance | Certificate of compliance | 11/02/2021 |
| Final Receipt | Final Receipt | 11/02/2021 |
| Final Short Form Prospectus | Final Short Form Prospectus | 11/02/2021 |
Each Warrant shall, entitle the holder thereof to acquire one (1) Common Share after the Issue Date and prior to the Expiry Time, upon payment of the Exercise Price of $0.70.
See the Warrant Indenture for full details.
| File | Type | Date |
|---|---|---|
| FORM 7 MONTHLY PROGRESS REPORT | Monthly Progress Report | 04/03/2021 |
| Material Change Report | Material Change Report | 25/02/2021 |
| Form 6 - Certificate of Compliance | Certificate of compliance | 25/02/2021 |
| Form 9 - Notice of Issuance of Securities | Proposed Issuance of Listed Securities | 25/02/2021 |
| CDS Summary Report | Confirmation from CDS | 16/02/2021 |
| Indenture | Indenture | 16/02/2021 |
| Form 6 - Certificate of Compliance | Certificate of compliance | 11/02/2021 |
| Final Receipt | Final Receipt | 11/02/2021 |
| Final Short Form Prospectus | Final Short Form Prospectus | 11/02/2021 |
Chaque bon de souscription donne à son détenteur le droit, lors de son exercice à tout moment après la date d'émission et avant l'heure d'expiration, d'acquérir une (1) action ordinaire sur paiement du prix d'exercice de 1,00 $.
Voir l'acte de mandat pour plus de détails.
| File | Type | Date |
|---|---|---|
| MATERIAL CHANGE REPORT | Material Change Report | 06/05/2022 |
| CSE Form 7 - Month of April | Monthly Progress Report | 06/05/2022 |
| Form 7 monthly progress report - March 2022 | Monthly Progress Report | 06/04/2022 |
| CSE Form 7 | Monthly Progress Report | 06/03/2022 |
| Material Change Report | Material Change Report | 15/02/2022 |
| Form 7 - January 2022 | Monthly Progress Report | 07/02/2022 |
| Material Change Report | Material Change Report | 07/01/2022 |
| Form 7 - December 2021 | Monthly Progress Report | 07/01/2022 |
| Form 11 - Notice of Stock Option issuacence | Proposed Stock Option | 30/12/2021 |
Each Warrant shall entitle the warrantholder thereof, upon exercise at any time after the Issue Date and prior to the expiry time, to acquire one (1) common share upon payment of the Exercise Price of $1.00.
See the Warrant Indenture for full details.
| File | Type | Date |
|---|---|---|
| MATERIAL CHANGE REPORT | Material Change Report | 06/05/2022 |
| CSE Form 7 - Month of April | Monthly Progress Report | 06/05/2022 |
| Form 7 monthly progress report - March 2022 | Monthly Progress Report | 06/04/2022 |
| CSE Form 7 | Monthly Progress Report | 06/03/2022 |
| Material Change Report | Material Change Report | 15/02/2022 |
| Form 7 - January 2022 | Monthly Progress Report | 07/02/2022 |
| Material Change Report | Material Change Report | 07/01/2022 |
| Form 7 - December 2021 | Monthly Progress Report | 07/01/2022 |
| Form 11 - Notice of Stock Option issuacence | Proposed Stock Option | 30/12/2021 |
Highlander Silver est une société d'exploration minière axée sur l'exploration du projet polymétallique d'argent Alta Victoria dans le centre du Pérou, ainsi que sur l'acquisition de projets miniers supplémentaires en tirant parti de l'expérience significative de l'équipe au Pérou et en Amérique du Sud plus largement.
